BU-NOT-SET

CONTACT US
Serialisation | the past, the present and the future
  • Manufacturing
Eyes
Insight
Mergers and acquisitions | meeting customer demand
  • Industry trends
Eyes
Insight
DSCSA deadline | our views
  • Manufacturing
Eyes
Insight
Serialisation: an investment not an expense
  • Manufacturing
Eyes
Insight
Solving the solubility setback
  • Drug product
Eyes
Insight
Pharmaceutical mega-trends: the rise of consolidation
  • Industry trends
Eyes
Insight
What the new Drug Supply Chain Security Act (DSCSA) deadline means for the industry
  • Manufacturing
Eyes
Insight
Automating excipient selection using high-throughput screening
  • Drug substance
Eyes
Insight
Serialisation: is the industry ready?
  • Manufacturing
Eyes
Insight
Insight
  • Drug product
  • Industry trends
Challenges and solutions to enhancing mRNA stability with lyophilisation processes
Insight
  • Industry trends
  • Manufacturing
A well-equipped CDMO for OSD contract manufacturing
Insight
  • Analytical chemistry
  • Industry trends
Optimising efficiency with technological innovation in analytical testing
Brochure
  • Biologics
Progress your biologic with Advanced Bio comprehensive services
Insight
  • Biologics
Innovation & leadership across the advanced therapy space
Insight
  • Biologics
Overcoming oncolytic virus obstacles with the help of a CDMO partnership
Webinar
  • Biologics
Webinar: Beyond borders: Navigating global scale-up for viral-based therapies
eBook
  • Drug product
Choosing the right container for your sterile drug product
White paper
  • Biologics
Cell and virus banking in OV development and manufacturing